Current Management Strategy for Active Surveillance in Prostate Cancer.

about

Survival outcomes for patients with localised upper tract urothelial carcinoma managed with non-definitive treatment.Patient and provider experiences with active surveillance: A scoping review.Emerging biomarkers in the diagnosis of prostate cancer.

P2860

Q47875264-3B54210B-2A1F-4EF1-B3E9-9CD0D9EB08D2 Q48105242-EE6E71C3-11E5-4ABC-9764-6FB7E8C9C437 Q54964875-9F376FEE-710F-40F3-9AE6-1F615662EEEF

P2860

Current Management Strategy for Active Surveillance in Prostate Cancer.

Item

http://www.wikidata.org/entity/Q38950908

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Current Management Strategy for Active Surveillance in Prostate Cancer.

@en

type

Item

label

Current Management Strategy for Active Surveillance in Prostate Cancer.

@en

prefLabel

Current Management Strategy for Active Surveillance in Prostate Cancer.

@en

P1476

Current Management Strategy for Active Surveillance in Prostate Cancer.

@en

P2093

Ansh Bhagat

http://www.w3.org/2001/XMLSchema#string

Jamil S Syed

http://www.w3.org/2001/XMLSchema#string

Juan Javier-Desloges

http://www.w3.org/2001/XMLSchema#string

Kevin A Nguyen

http://www.w3.org/2001/XMLSchema#string

Kevin Hwang

http://www.w3.org/2001/XMLSchema#string

Preston C Sprenkle

http://www.w3.org/2001/XMLSchema#string

Sarah Kim

http://www.w3.org/2001/XMLSchema#string

Stephanie Tatzel

http://www.w3.org/2001/XMLSchema#string

P2860

Incorporation of tissue-based genomic biomarkers into localized prostate cancer clinics

Biomarkers in prostate cancer: what's new?

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

Active surveillance for prostate cancer: current evidence and contemporary state of practice

PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2

Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer.

Validation of a genomic classifier that predicts metastasis following radical prostatectomy in an at risk patient population.

Targeted prostate biopsy in select men for active surveillance: do the Epstein criteria still apply?

PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy.

PCA3: a molecular urine assay for predicting prostate biopsy outcome.

P2888

s11912-017-0569-6

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11912-017-0569-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1083852170

http://www.w3.org/2001/XMLSchema#string

P698

28220449

http://www.w3.org/2001/XMLSchema#string

Current Management Strategy for Active Surveillance in Prostate Cancer.

about

P2860

P2860

Current Management Strategy for Active Surveillance in Prostate Cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698